Standard BioTools

LAB

----

Q1 FY2026 Earnings

Financial report interval: 2025.12.31 - 2026.03.31

Preview: Standard BioTools(LAB) predict that the Revenue is 21.15 M (-48.17%), Beat estimate;the EBIT is -12.5 M (+62.1%), Beat estimate;the EPS is -0.04 (+42.86%), Beat estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueExceed expectations

0.02B48.17%

0.02B56.37%

+0.00B8.20%

EBITExceed expectations

-0.01B62.10%

-0.02B27.96%

+0.01B34.14%

EPSExceed expectations

-0.0442.86%

-0.0614.29%

+0.020028.57%

Upcoming earnings report - FY2026 Q2 Earning Release

Available dateAug 5, 2026

Estimate Revenue20.8 M

Estimate EBIT-9.7 M

Estimate EPS-0.03

Revenue

ActualEstimateUnit: USD

EBIT

ActualEstimateUnit: USD

Net income

ActualEstimateUnit: USD

EPS

ActualEstimateUnit: USD